Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.2913
-0.0138 (-4.52%)
At close: Apr 1, 2025, 4:00 PM
0.2942
+0.0029 (1.00%)
After-hours: Apr 1, 2025, 7:50 PM EDT
Leap Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
54
Market Cap
12.02M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
LPTX News
- 1 day ago - Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript - Seeking Alpha
- 6 days ago - Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer - Benzinga
- 6 days ago - Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 6 days ago - Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study - PRNewsWire
- 2 months ago - Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study - PRNewsWire
- 3 months ago - Leap Therapeutics: A Buy On Near-Term Data Catalysts In Stomach And Colon Cancer - Seeking Alpha
- 3 months ago - Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 months ago - Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference - PRNewsWire